NCT02181582View on ClinicalTrials.gov

Specific PET Radioligand Binding to Translocator Protein

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 24, 2014

Primary Completion Date

June 16, 2016

Study Completion Date

November 23, 2016

Conditions
BaselineBlocking Receptor Binding
Interventions
DRUG

Emapunil

Single peroral administration

DEVICE

PET

Positron emission tomography, which creates images by detecting radioactivity.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT02181582 - Specific PET Radioligand Binding to Translocator Protein | Biotech Hunter | Biotech Hunter